Literature DB >> 16211251

A novel single-nucleotide substitution, Glu 4 Lys, in the leukotriene C4 synthase gene associated with allergic diseases.

Kaori Yoshikawa1, Eiko Matsui, Hideo Kaneko, Toshiyuki Fukao, Ryosuke Inoue, Takahide Teramoto, Shinji Shinoda, Osamu Fukutomi, Minako Aoki, Kimiko Kasahara, Naomi Kondo.   

Abstract

Cysteinyl leukotrienes (cysLTs) play important roles in bronchial asthma, and can mediate bronchial smooth muscle constriction and increase mucous secretion, vascular permeability and cellular infiltration. We identified a novel heterozygous single-nucleotide substitution 10G>A (Glu 4 Lys) in the first exon of the leukotriene C4 synthase gene (LTC4S). This substitution was detected in 5 of 141 allergic patients, but not in 110 nonallergic subjects. There was a difference in the Glu 4 Lys frequency between the allergic patients and nonallergic subjects (Fisher's exact test, p=0.0460). The five patients with Glu 4 Lys had allergic diseases such as bronchial asthma and/or allergic dermatitis. Furthermore, a familial analysis of Glu 4 Lys revealed a link with allergic diseases. Thus, our results suggest that Glu 4 Lys in the LTC4S might be associated with allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16211251

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  2 in total

1.  Relationship between the benefits of suplatast tosilate, a Th2 cytokine inhibitor, and gene polymorphisms in children with bronchial asthma.

Authors:  Eiko Matsui; Shinji Shinoda; Osamu Fukutomi; Hideo Kaneko; Toshiyuki Fukao; Naomi Kondo
Journal:  Exp Ther Med       Date:  2010-09-15       Impact factor: 2.447

2.  Pharmacogenetics of asthma in children.

Authors:  Naomi Kondo; Eiko Matsui; Akane Nishimura; Hideo Kaneko
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.